Monday, February 13, 2012

Big Business and health care

We try not to get political in our blog, but I read something in the New York Times yesterday which was so upsetting that I must address it.  http://www.nytimes.com/2012/02/11/health/policy/supply-of-methotrexate-a-cancer-drug-may-run-out-soon.html

This is near and dear to my heart.  My daughter was diagnosed with leukemia (ALL) when she was seven weeks old.  She was treated with an experimental chemotherapy protocol which has now become the gold standard for this type of cancer.  One of the key drugs in this protocol is methotrexate.  This drug kills the cancer cells in the brain and spinal fluid and replaces radiation which is extremely damaging to children under the age of one.  My daughter was blessed to be treated with this drug regime.  She was a straight A student in high school and is consistently on the Dean's list at UW-Madison.  Her cure and her healthy brain is due in part to the methotrexate.  I find it horrifying that our country allows shortages like this to occur.  The health of our children, of all citizens of this country needs to come ahead of t the drug companies need to make money.  I really hope the government figures out how to fix health care in our country, because from the drug companies to the health insurance companies, it seems the CEOs and stockholders are the only ones benefiting from the current system. Please make sure you understand your legislators know where you stand when it comes to health care reform in the United States.

Susan

1 comment:

  1. Because this is such a critical issue, I would ask that you check your premises.
    Please consider the possibility that gov't regulation might actually be the cause of these shortages.
    http://blog.aynrandcenter.org/shortage-of-drugs-abundance-of-regulations/

    ReplyDelete